Altered sensitivity to excitotoxic cell death and glutamate receptor expression between two commonly studied mouse strains

Journal of Neuroscience Research

Volumn 88, Issue 12, 2010, Pages 2648-2660

  Finn, Rozzy ^a,b   Kovács, Attila D ^a,b   Pearce, David A ^a,b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b SANFORD RESEARCH   (United States)

Author keywords

129S6 SvEv; AMPA; C57BL 6J; Glutamate receptor; NMDA; Strain differences

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CELL SURFACE RECEPTOR; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CELL DEATH; CEREBELLUM; CONTROLLED STUDY; CROSS LINKING; DRUG SENSITIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXCITOTOXICITY; GENE MUTATION; GRANULE CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SENSITIVITY ANALYSIS; STRAIN DIFFERENCE; WESTERN BLOTTING;

ALANINE; ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; ANIMALS, NEWBORN; CELL DEATH; CELL SURVIVAL; CELLS, CULTURED; CEREBELLAR CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; EXCITATORY AMINO ACID AGONISTS; MALE; MICE; MICE, INBRED C57BL; N-METHYLASPARTATE; NERVE DEGENERATION; NEUROTOXINS; ORGAN CULTURE TECHNIQUES; PYRIMIDINONES; RECEPTORS, GLUTAMATE; SPECIES SPECIFICITY;

EID: 77955491129     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22433     Document Type: Article

References (53)

1. Aras MA, Hartnett KA, Aizenman E. 2008. Assessment of cell viability in primary neuronal cultures. Curr Protoc Neurosci, Chapter 7, Unit 7 18.
2. Balogh SA, McDowell CS, Stavnezer AJ, Denenberg VH. 1999. A behavioral and neuroanatomical assessment of an inbred substrain of 129 mice with behavioral comparisons to C57BL/6J mice. Brain Res 836:38-48.
3. Beattie EC, Carroll RC, Yu X, Morishita W, Yasuda H, von Zastrow M, Malenka RC. 2000. Regulation of AMPA receptor endocytosis by a signaling mechanism shared with LTD. Nat Neurosci 3:1291-1300.
4. Bilovocky NA, Romito-DiGiacomo RR, Murcia CL, Maricich SM, Herrup K. 2003. Factors in the genetic background suppress the engrailed-1 cerebellar phenotype. J Neurosci 23:5105-5112.
5. Bothe GW, Bolivar VJ, Vedder MJ, Geistfeld JG. 2004. Genetic and behavioral differences among five inbred mouse strains commonly used in the production of transgenic and knockout mice. Genes Brain Behav 3:149-157.
6. Boudreau AC, Wolf ME. 2005. Behavioral sensitization to cocaine is associated with increased AMPA receptor surface expression in the nucleus accumbens. J Neurosci 25:9144-9151.
7. Campiani G, Morelli E, Nacci V, Fattorusso C, Ramunno A, Novellino E, Greenwood J, Liljefors T, Griffiths R, Sinclair C, Reavy H, Kristensen AS, Pickering DS, Schousboe A, Cagnotto A, Fumagalli E, Mennini T. 2001. Characterization of the 1H-cyclopentapyrimidine- 2,4(1H,3H)-dione derivative (S)-CPW399 as a novel, potent, and subtype-selective AMPA receptor full agonist with partial desensitization properties. J Med Chem 44:4501-4504.
8. Conrad KL, Tseng KY, Uejima JL, Reimers JM, Heng LJ, Shaham Y, Marinelli M, Wolf ME. 2008. Formation of accumbens GluR2-lacking AMPA receptors mediates incubation of cocaine craving. Nature 454:118-121. (Pubitemid 351931970)
9. Cook MN, Bolivar VJ, McFadyen MP, Flaherty L. 2002. Behavioral differences among 129 substrains: implications for knockout and transgenic mice. Behav Neurosci 116:600-611.
10. Crabbe JC, Wahlsten D, Dudek BC. 1999. Genetics of mouse behavior: interactions with laboratory environment. Science 284:1670-1672.
11. Didier M, Xu M, Berman SA, Saido TC, Bursztajn S. 1997. Involvement of three glutamate receptor epsilon subunits in the formation of N-methyl-D-aspartate receptors mediating excitotoxicity in primary cultures of mouse cerebellar granule cells. Neuroscience 78:1129-1146.
12. Duysen EG, Lockridge O. 2006. Phenotype comparison of three acetylcholinesterase knockout strains. J Mol Neurosci 30:91-92. (Pubitemid 46035334)
13. Estrada Sanchez AM, Mejia-Toiber J, Massieu L. 2008. Excitotoxic neuronal death and the pathogenesis of Huntington's disease. Arch Med Res 39:265-276.
14. Fujii M, Hara H, Meng W, Vonsattel JP, Huang Z, Moskowitz MA. 1997. Strain-related differences in susceptibility to transient forebrain ischemia in SV-129 and C57black/6 mice. Stroke 28:1805-1810; discussion 1811.
15. Gao C, Wolf ME. 2007. Dopamine alters AMPA receptor synaptic expression and subunit composition in dopamine neurons of the ventral tegmental area cultured with prefrontal cortex neurons. J Neurosci 27:14275-14285.
16. Gardoni F, Di Luca M. 2006. New targets for pharmacological intervention in the glutamatergic synapse. Eur J Pharmacol 545:2-10. (Pubitemid 44215874)
17. Hack NJ, Sluiter AA, Balazs R. 1995. AMPA receptors in cerebellar granule cells during development in culture. Brain Res Dev Brain Res 87:55-61.
18. Hashimoto K, Fukaya M, Qiao X, Sakimura K, Watanabe M, Kano M. 1999. Impairment of AMPA receptor function in cerebellar granule cells of ataxic mutant mouse stargazer. J Neurosci 19:6027-6036.
19. Hefner K, Whittle N, Juhasz J, Norcross M, Karlsson RM, Saksida LM, Bussey TJ, Singewald N, Holmes A. 2008. Impaired fear extinction learning and cortico-amygdala circuit abnormalities in a common genetic mouse strain. J Neurosci 28:8074-8085.
20. Heng MY, Detloff PJ, Wang PL, Tsien JZ, Albin RL. 2009. In vivo evidence for NMDA receptor-mediated excitotoxicity in a murine genetic model of Huntington disease. J Neurosci 29:3200-3205.
21. Jensen P, Surmeier DJ, Goldowitz D. 1999. Rescue of cerebellar granule cells from death in weaver NR1 double mutants. J Neurosci 19:7991-7998.
22. Johansen TH, Chaudhary A, Verdoorn TA. 1995. Interactions among GYKI-52466, cyclothiazide, and aniracetam at recombinant AMPA and kainate receptors. Mol Pharmacol 48:946-955.
23. Kelly MA, Rubinstein M, Phillips TJ, Lessov CN, Burkhart-Kasch S, Zhang G, Bunzow JR, Fang Y, Gerhardt GA, Grandy DK, Low MJ. 1998. Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations. J Neurosci 18:3470-3479.
24. Kew JN, Kemp JA. 2005. Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology 179:4-29. (Pubitemid 40576690)
25. v strain and modulates working memory in mice. Proc Natl Acad Sci U S A 103:3693-3697.
26. Kovacs AD, Pearce DA. 2008. Attenuation of AMPA receptor activity improves motor skills in a mouse model of juvenile Batten disease. Exp Neurol 209:288-291.
27. Kovacs AD, Cebers G, Cebere A, Moreira T, Liljequist S. 2001. Cortical and striatal neuronal cultures of the same embryonic origin show intrinsic differences in glutamate receptor expression and vulnerability to excitotoxicity. Exp Neurol 168:47-62.
28. Kovacs AD, Weimer JM, Pearce DA. 2006. Selectively increased sensitivity of cerebellar granule cells to AMPA receptor-mediated excitotoxicity in a mouse model of Batten disease. Neurobiol Dis 22:575-585.
29. Lariviere WR, Chesler EJ, Mogil JS. 2001. Transgenic studies of pain and analgesia: mutation or background genotype? J Pharmacol Exp Ther 297:467-473.
30. Lee SH, Simonetta A, Sheng M. 2004. Subunit rules governing the sorting of internalized AMPA receptors in hippocampal neurons. Neuron 43:221-236.
31. Liu Y, Peterson DA, Kimura H, Schubert D. 1997. Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J Neurochem 69:581-593.
32. Lloret A, Dragileva E, Teed A, Espinola J, Fossale E, Gillis T, Lopez E, Myers RH, MacDonald ME, Wheeler VC. 2006. Genetic background modifies nuclear mutant huntingtin accumulation and HD CAG repeat instability in Huntington's disease knock-in mice. Hum Mol Genet 15:2015-2024.
33. Longone P, Impagnatiello F, Mienville JM, Costa E, Guidotti A. 1998. Changes in AMPA receptor-spliced variant expression and shift in AMPA receptor spontaneous desensitization pharmacology during cerebellar granule cell maturation in vitro. J Mol Neurosci 11:23-41. (Pubitemid 28527378)
34. Magara F, Muller U, Li ZW, Lipp HP, Weissmann C, Stagljar M, Wolfer DP. 1999. Genetic background changes the pattern of forebrain commissure defects in transgenic mice underexpressing the beta-amyloid-precursor protein. Proc Natl Acad Sci U S A 96:4656-4661.
35. Mahajan MA, Das S, Zhu H, Tomic-Canic M, Samuels HH. 2004. The nuclear hormone receptor coactivator NRC is a pleiotropic modulator affecting growth, development, apoptosis, reproduction, and wound repair. Mol Cell Biol 24:4994-5004.
36. Michaelis EK. 1998. Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging. Prog Neurobiol 54:369-415.
37. Mizuta I, Katayama M, Watanabe M, Mishina M, Ishii K. 1998. Developmental expression of NMDA receptor subunits and the emergence of glutamate neurotoxicity in primary cultures of murine cerebral cortical neurons. Cell Mol Life Sci 54:721-725.
38. Montkowski A, Poettig M, Mederer A, Holsboer F. 1997. Behavioural performance in three substrains of mouse strain 129. Brain Res 762:12-18. (Pubitemid 27315929)
39. Mosbacher J, Schoepfer R, Monyer H, Burnashev N, Seeburg PH, Ruppersberg JP. 1994. A molecular determinant for submillisecond desensitization in glutamate receptors. Science 266:1059-1062.
40. Nakamoto M, Nalavadi V, Epstein MP, Narayanan U, Bassell GJ, Warren ST. 2007. Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors. Proc Natl Acad Sci U S A 104:15537-15542.
41. Nguyen M, Camenisch T, Snouwaert JN, Hicks E, Coffman TM, Anderson PA, Malouf NN, Koller BH. 1997. The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth. Nature 390:78-81. (Pubitemid 27494759)
42. Partin KM, Patneau DK, Mayer ML. 1994. Cyclothiazide differentially modulates desensitization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor splice variants. Mol Pharmacol 46:129-138. (Pubitemid 24984437)
43. Partin KM, Fleck MW, Mayer ML. 1996. AMPA receptor flip/flop mutants affecting deactivation, desensitization, and modulation by cyclothiazide, aniracetam, and thiocyanate. J Neurosci 16:6634-6647.
44. Paulus MP, Dulawa SC, Ralph RJ, Mark AG. 1999. Behavioral organization is independent of locomotor activity in 129 and C57 mouse strains. Brain Res 835:27-36.
45. Pickard L, Noel J, Henley JM, Collingridge GL, Molnar E. 2000. Developmental changes in synaptic AMPA and NMDA receptor distribution and AMPA receptor subunit composition in living hippocampal neurons. J Neurosci 20:7922-7931.
46. Pollak D, Weitzdoerfer R, Yang YW, Prast H, Hoeger H, Lubec G. 2005. Cerebellar protein expression in three different mouse strains and their relevance for motor performance. Neurochem Int 46:19-29. (Pubitemid 39572783)
47. Schauwecker PE, Steward O. 1997. Genetic determinants of susceptibility to excitotoxic cell death: implications for gene targeting approaches. Proc Natl Acad Sci U S A 94:4103-4108.
48. Simpson EM, Linder CC, Sargent EE, Davisson MT, Mobraaten LE, Sharp JJ. 1997. Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice. Nat Genet 16:19-27.
49. Tang Y, McKinnon ML, Leong LM, Rusholme SA, Wang S, Akhurst RJ. 2003. Genetic modifiers interact with maternal determinants in vascular development of Tgfb1(-/-) mice. Hum Mol Genet 12:1579-1589.
50. Tarantino LM, Gould TJ, Druhan JP, Bucan M. 2000. Behavior and mutagenesis screens: the importance of baseline analysis of inbred strains. Mamm Genome 11:555-564.
51. vTac inbred mice. Psychopharmacology 184:145-154.
52. van Bogaert MJ, Groenink L, Oosting RS, Westphal KG, van der Gugten J, Olivier B. 2006. Mouse strain differences in autonomic responses to stress. Genes Brain Behav 5:139-149. (Pubitemid 43348555)
53. Yang T, Huang YG, Ye W, Hansen P, Schnermann JB, Briggs JP. 2005. Influence of genetic background and gender on hypertension and renal failure in COX-2-deficient mice. Am J Physiol Renal Physiol 288:F1125-F1132.